NEW YORK (GenomeWeb News) – Co-Diagnostics HBDC and Mentors International have inked an agreement to offer real-time PCR-based tests in developing nations at lower costs, they announced today.

Starting with a pilot program in Guatemala and an initial testing focus on tuberculosis, Co-Diagnostics HBDC will provide low-cost testing reagents, and Mentors will leverage its international network to create low-cost testing facilities. Mentors will identify machines that cost less and provide training to second-generation workers in its microfinancing program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.